PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit speaks with PanCAN’s Chief Business Officer, Sudheer Doss, PhD, ...
New platform offers vital peer-to-peer support, shared experiences, and practical knowledge for those affected by pancreatic ...
Pancreatic cancer researcher Dr. Luisa Escobar-Hoyos spoke at a Congressional hearing about the importance of federal funding ...
Cancer ghosting is when a friend, acquaintance or family member who was present in a person’s life before a cancer diagnosis disappears without explanation, leaving feelings of sadness and anxiety for ...
The administration’s fiscal year 2026 proposed budget included devastating cuts to the National Institutes of Health (NIH) and National Cancer Institute (NCI). In response, and as Congress returns to ...
PanCAN welcomes Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum to the Board of Directors. In this Q&A, Jon shares his personal connection to the cause, his passion ...
A new PanCAN-authored paper uses feedback provided by patients with pancreatic cancer to identify trends in reporting pain. Among the key findings: Pain is more likely to be reported by pancreatic ...
Joining the Board this year is Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum, a leading health solution and care delivery organization. Mahrt brings a deep ...
LOS ANGELES, CALIF. – (July 2, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, today announced a new data partnership ...
Every year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together the world’s leading cancer researchers, clinicians and advocates. The 2025 meeting held on May 30-June 3 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback